Ralph Lauren announces Korea center; Ralph Lauren stock trades EUR 322.95 versus EUR 322.95
Published on 10/04/2026 at 17:11 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Ralph Lauren announced a partnership on September 8, 2026, to establish a cancer center in Korea, according to a Ralph Lauren Corporation investor-relations release. In weekend trading at Lang & Schwarz on October 4, 2026, Ralph Lauren stock was at EUR 322.95 at 5:09 p.m. CEST, unchanged at 0.00 percent versus the EUR 322.95 close at Lang & Schwarz on October 2, 2026.
Weekend trading
The EUR 322.95 price was quoted by Lang & Schwarz at 5:09 p.m. CEST on October 4, 2026. The bid was EUR 322.30 and the ask was EUR 323.60. The further course of weekend trading at Lang & Schwarz until 7:00 p.m. CET/CEST is shown by the continuously updated real-time quote of Ralph Lauren stock.
Last Xetra trading day
The reference close at Lang & Schwarz was EUR 322.95 on October 2, 2026. Xetra remains closed on October 4, 2026, with the next Xetra session scheduled for October 5, 2026.
Company development
The planned Ralph Lauren Center for Patient and Family Recovery will be established at the National Cancer Center of Korea in Goyang. Ralph Lauren Corporation said the facility will provide a recovery environment for cancer patients, families and caregivers, and is expected to open in 2028. The center will be located within the Phase II Proton Therapy Center at the National Cancer Center’s new Innovative Cancer Research Center, according to the company’s release.
Next Xetra session
The next Xetra session is October 5, 2026. The company announcement and the Lang & Schwarz price are separate dated facts.
